Age-related cognitive decline and nesting behavior in an APPswe/PS1 bigenic model of Alzheimer's disease

Brain Research

Volumn 1292, Issue , 2009, Pages 93-99

  Filali, Mohammed ^a   Lalonde, Robert ^b,c  

^a LAVAL UNIVERSITY   (Canada)

^b CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^c UNIVERSITÉ DE ROUEN   (France)

Author keywords

Aging; Alzheimer's disease; Memory; Nesting behavior; Passive avoidance; Perseverative tendency; Spatial learning; Transgenic model

Indexed keywords

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; GENE MUTATION; LEARNING; MALE; MAZE TEST; MOUSE; NESTING; NONHUMAN; PRIORITY JOURNAL; TRANSGENIC MOUSE;

MUS; MUS MUSCULUS;

EID: 69449089051     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2009.07.066     Document Type: Article

References (34)

1. Ashe K.H. Learning and memory in transgenic mice modeling Alzheimer's disease. Learn. Mem. 8 (2001) 301-308
2. Bellucci A., Luccarini I., Scali C., Prosperi C., Giovannini M.G., Pepeu G., and Casamenti F. Cholinergic dysfunction, neuronal damage and axonal loss in TgCRND8 mice. Neurobiol. Dis. 23 (2006) 260-272
3. Borchelt D.R., van Lare J., Lee M.K., Gonzalez V., Jenkins N.A., Copeland N.G., Price D.L., and Sisodia S.S. Familial Alzheimer's disease-linked presenilin 1 variants elevate Ab1-42/1-40 ratio in vitro and in vivo. Neuron 17 (1996) 1005-1013
4. Borchelt D.R., Thinakaran G., Eckman C.B., Lee M.K., Davenport F., Ratovitsky T., Prada C.M., Kim G., Seekins S., Yager D., Slunt H.H., Wang R., Seeger M., Levey A.I., Gandy S.E., Copeland N.G., Jenkins N.A., Price D.L., Younkin S.G., and Sisodia S.S. Accelerated amyloid deposition in the brains of transgenic mice coexpressing mutant presenilin 1 and amyloid precursor proteins. Neuron 19 (1997) 939-945
5. Busche M.A., Eichhoff G., Adelsberger H., Abramowski D., Wiederhold K.H., Haass C., Staufenbiel M., Konnerth A., and Garaschuk O. Clusters of hyperactive neurons near amyloid plaques in a mouse model of Alzheimer's disease. Science 321 (2008) 1686-1699
6. Carroll J.C., Rosario E.R., Chang L., Stanczyk F.Z., Oddo S., LaFerla F.M., and Pike C.J. Progesterone and estrogen regulate Alzheimer-like neuropathology in female 3xTg-AD mice. J. Neurosci. 27 (2007) 13357-13365
7. Chung J.A., and Cummings J.L. Neurobehavioral and neuropsychiatric symptoms in Alzheimer's disease. Neurol. Clin. 18 (2000) 829-846
8. Clinton L.K., Billings L.M., Green K.N., Caccamo A., Ngo J., Oddo S., McGaugh J.L., and LaFerla F.M. Age-dependent sexual dimorphism in cognition and stress response in the 3xTg-AD mice. Neurobiol. Dis. 28 (2007) 76-82
9. Deacon R.M.J., Cholerton L.L., Talbot K., Nair-Roberts R.G., Sanderson D.J., Romberg C., Koros E., Bornemann K.D., and Rawlins J.N.P. Age-dependent and -independent behavioral deficits in Tg2576 mice. Behav. Brain Res. 189 (2008) 126-138
10. Filali M., Lalonde R., and Rivest S. Cognitive and non-cognitive behaviors in an APPswe/PS1 bigenic model of Alzheimer's disease. Genes Brain Behav. 8 (2009) 143-148
11. Frisoni G.B., Rozzini L., Gozetti A., Binetti G., Zanetti O., Bianchetti A., Trabucchi M., and Cummings J.L. Behavioral syndromes in Alzheimer's disease: description and correlates. Dement. Geriatr. Cogn. Disord. 10 (1999) 130-138
12. Galvan V., Gorostiza O.F., Banwait S., Ataie M., Logvinova A.V., Sitaraman S., Carlson E., Sagi S.A., Chevallier N., Jin K., Greenberg D.A., and Bredesen D.E. Reversal of Alzheimer's-like pathology and behavior in human APP transgenic mice by mutation of Asp664. Proc. Natl. Acad. Sci. U. S. A. 103 (2006) 7130-7135
13. Holcomb L., Gordon M.N., McGowan E., Yu X., Benkowic S., Jantzen P., Wright K., Saad I., Mueller R., Morgan D., Sanders S., Zehr C., O'Campo K., Hardy J., Prada C.-M., Eckman C., Younkin S., Hsiao K., and Duff K. Accelerated Alzheimer-type phenotype in transgenic mice carrying both mutant amyloid precursor protein and presenilin transgenes. Nat. Med. 4 (1998) 97-100
14. Holcomb L.A., Gordon M.N., Jantzen P., Hsiao K., Duff K., and Morgan D. Behavioral changes in transgenic mice expressing both amyloid precursor protein and presenilin-1 mutations: lack of association with amyloid deposits. Behav. Genet. 29 (1999) 177-185
15. Huang S.M., Mouri A., Kokubo H., Nakajima R., Suemoto T., Higuchi M., Staufenbiel M., Noda Y., Yamaguchi H., Nabeshima T., Saido T.C., and Iwata N. Neprilysin-sensitive synapse-associated amyloid-beta peptide oligomers impair neuronal plasticity and cognitive function. J. Biol. Chem. 281 (2006) 17941-17951
16. Ikarashi Y., Harigaya Y., Tomidokoro Y., Kanai M., Ikeda M., Matsubara E., Kawarabayashi T., Kuribara H., Younkin S.G., Maruyama Y., and Shoji M. Decreased level of brain acetylcholine and memory disturbance in APPsw mice. Neurobiol. Aging 25 (2004) 483-490
17. King D.L., and Arendash G.W. Behavioral characterization of the Tg2576 transgenic model of Alzheimer's disease through 19 months. Physiol. Behav. 5 (2002) 627-642
18. Kolb B. Functions of the frontal cortex of the rat: a comparative review. Brain Res. 320 (1984) 65-98
19. Lalonde R. The neurobiological basis of spontaneous alternation. Neurosci. Biobehav. Rev. 26 (2002) 91-104
20. 695SWE (Tg2576) mice with the Swedish mutation. Brain Res. 977 (2003) 38-45
21. Lesné S., Koh M.T., Kotilinek L., Kayed R., Glabe C.G., Yang A., Gallagher M., and Ashe K.H. A specific amyloid-β protein assembly in the brain impairs memory. Nature 440 (2006) 352-357
22. Lin L., Chen G., Wang D., and Tsien J.Z. Neural encoding of the concept of nest in the mouse brain. Proc. Natl. Acad. Sci. U. S. A. 104 (2007) 6066-6071
23. Liu L., Ikonen S., Heikkinen T., Tapiola T., van Groen T., and Tanila H. The effects of long-term treatment with metrifonate, a cholinesterase inhibitor, on cholinergic activity, amyloid pathology, and cognitive function in APP and PS1 doubly transgenic mice. Exp. Neurol. 173 (2002) 196-204
24. Lindner M.D., Hogan J.B., Krause R.G., Machet F., Bourin C., Hodges Jr. D.B., Corsa J.A., Barten D.M., Toyn J.H., Stock D.A., Rose G.M., and Gribkoff V.K. Soluble Aβ and cognitive function in aged F-344 rats and Tg2576 mice. Behav. Brain Res. 173 (2006) 62-75
25. Marutle A., Unger C., Hellstrom-Lindahl E., Wang J., Puolivali J., Tanila H., Nordberg A., and Zhang X. Elevated levels of Ab1-40 and Ab1-42 do not alter the binding sites of nicotinic receptor subtypes in the brain of APPswe and PS1 double transgenic mice. Neurosci. Lett. 328 (2002) 269-272
26. Oakley H., Cole S.L., Logan S., Maus E., Shao P., Craft J., Guillozet-Bongaarts A., Ohno M., Disterhoft J., Van Eldik L., Berry R., and Vassar R. Intraneuronal β-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer's disease mutations: potential factors in amyloid plaque formation. J. Neurosci. 26 (2006) 10129-10140
27. Pietropaolo S., Sun Y., Li R., Brana C., Feldon J., and Yee B.K. Limited impact of social isolation on Alzheimer-like symptoms in a triple transgenic model. Behav. Neurosci. 123 (2009) 181-195
28. Puoliväli J., Wang J., Heikkinen T., Heikkilä M., Tapiola T., van Groen T., and Tanila H. Hippocampal Ab42 levels correlate with spatial memory deficit in APP and PS1 double transgenic mice. Neurobiol. Dis. 9 (2002) 339-347
29. Richards J.G., Higgins G.A., Ouagazzal A.-M., Ozmen L., Kew J.N.C., Bohrmann B., Malherbe P., Brockhaus M., Loetscher H., Czech C., Huber G., Bluethmann H., Jacobsen H., and Kemp J.A. PS2APP transgenic mice, coexpressing hPS2mut and hAPPswe, show age-related cognitive deficits associated with discrete brain amyloid deposition and inflammation. J. Neurosci. 23 (2003) 8989-9003
30. Richardson J.C., Kendal C.E., Anderson R., Priest F., Gower E., Soden P., Gray R., Topps S., Howlett D.R., Lavender D., Clarke N.J., Barnes J.C., Haworth R., Stewart M.G., and Rupniak H.T.R. Ultrastructural and behavioural changes precede amyloid deposition in a transgenic model of Alzheimer's disease. Neuroscience 122 (2003) 213-228
31. Rogers D.C., Jones D.N.C., Nelson P.R., Jones C.M., Quilter C.A., Robinson T.L., and Hagan J.J. Use of SHIRPA and discriminant analysis to characterise marked differences in the behavioural phenotype of six inbred mouse strains. Behav. Brain Res. 105 (1999) 207-217
32. Savonenko A.V., Xu G.M., Price D.L., Borchelt D.R., and Markowska A.L. Normal cognitive behavior in two distinct congenic lines of transgenic mice hyperexpresing APPSWE. Neurobiol. Dis. 12 (2003) 194-211
33. Wang J., Tanila H., Puoliväli J., Kadish I., and van Groen T. Gender differences in the amount and deposition of amyloidb in APPswe and PS1 double transgenic mice. Neurobiol. Dis. 14 (2003) 318-327
34. Wirths O., Breyhan H., Schäfer S., Roth C., and Bayer T.A. Deficits in working memory and motor performance in the APP/PS1ki mouse model for Alzheimer's disease. Neurobiol. Aging 29 (2008) 891-901